A prospective randomized trial of Billroth-I versus Billroth-II reconstruction after pancreaticoduodenectomy with pancreaticogastrostomy reconstruction

A prospective randomized trial of Billroth-I versus Billroth-II reconstruction after pancreaticoduodenectomy with pancreaticogastrostomy reconstruction - A prospective randomized trial of Billroth-I versus Billroth-II reconstruction after pancreaticoduodenectomy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001957

Enrollment

Registered

2009-05-11

Start date

2008-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic tumor, bile duct tumor, ampullary tumor, duodenal tumor

Interventions

Perform Billroth I reconstruction after pancreaticoduodenectomy. Perform Billroth II reconstruction after pancreaticoduodenectomy.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases with pancreatic tumor, bile duct tumor, ampullary tumor, or duodenal tumor who received macroscopic curative resection by pancreticoduodenectomy. Performance status 0 or 1.

Exclusion criteria

Exclusion criteria: Case who did not received curative resection for cancer. Performance status 2 or 3.

Design outcomes

Primary

Measure	Time frame
Incidence of DGE and postoperative hospital stay in the postoeprative early period.	—

Secondary

Measure	Time frame
Evaluation of nutriture, digestive ability, and pancreatic endocrine/exocrine secretory function in the postoperative late period.	—

Countries

Japan

Contacts

Public ContactHiroshi Kurahara

Kagoshima University Surgical Oncology and Digestive Surgery

h-krhr@m3.kufm.kagoshima-u.ac.jp099-275-5361

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026